CJC-X

CJC-DAC (CJC-1295 with Drug Affinity Complex) is a long-acting synthetic analogue of growth hormone–releasing hormone (GHRH) extensively investigated for its influence on growth hormone and IGF-1 signaling. The Drug Affinity Complex is designed to extend the peptide’s circulating persistence, making CJC-DAC an important subject in research examining sustained endocrine signaling and physiological responses. Studies have explored its relationship with growth hormone release, metabolic regulation, tissue-related processes, and recovery mechanisms.Within exercise and performance research, CJC-DAC is investigated for its potential relationship with muscle adaptation, recovery processes, body-composition pathways, sleep-related physiology, and responses to physical training. Researchers continue to evaluate its pharmacokinetic characteristics, biological activity, safety profile, and potential applications in endocrine and peptide research. Further controlled studies are required to establish its efficacy and long-term effects.